Calamos Advisors LLC - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 54 filers reported holding EXAGEN INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of EXAGEN INC
ValueSharesWeighting
Q3 2021$160,000
-60.7%
11,768
-56.6%
0.00%
-50.0%
Q2 2021$407,000
-78.2%
27,141
-74.6%
0.00%
-80.0%
Q1 2021$1,871,000
+889.9%
106,947
+512.0%
0.01%
+900.0%
Q3 2020$189,000
-70.0%
17,474
-65.6%
0.00%
-75.0%
Q2 2020$631,000
-66.8%
50,794
-57.3%
0.00%
-73.3%
Q1 2020$1,898,000
-65.5%
119,071
-45.1%
0.02%
-44.4%
Q4 2019$5,505,000
+136.9%
216,802
+44.6%
0.03%
+107.7%
Q3 2019$2,324,000149,9770.01%
Other shareholders
EXAGEN INC shareholders Q4 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,203,491$2,912,4480.97%
PERKINS CAPITAL MANAGEMENT INC 263,905$6390.63%
COWEN AND COMPANY, LLC 842,376$2,063,8210.14%
Penbrook Management LLC 73,410$177,6520.13%
RTW INVESTMENTS, LP 1,492,432$3,611,6850.08%
Nantahala Capital Management 106,769$258,3810.02%
WASATCH ADVISORS LP 856,273$2,097,8690.01%
SILVERCREST ASSET MANAGEMENT GROUP LLC 544,877$1,318,6020.01%
First Bank & Trust 14,375$34,7880.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 40,800$99,9600.00%
View complete list of EXAGEN INC shareholders